TWI385384B - Detecting strip and the detecting method using the same - Google Patents

Detecting strip and the detecting method using the same Download PDF

Info

Publication number
TWI385384B
TWI385384B TW097139825A TW97139825A TWI385384B TW I385384 B TWI385384 B TW I385384B TW 097139825 A TW097139825 A TW 097139825A TW 97139825 A TW97139825 A TW 97139825A TW I385384 B TWI385384 B TW I385384B
Authority
TW
Taiwan
Prior art keywords
fluid
peroxide
zone
antibody
nitrocellulose
Prior art date
Application number
TW097139825A
Other languages
Chinese (zh)
Other versions
TW201017160A (en
Inventor
Yi Jen Wu
Wen Pin Hsieh
Chih Wei Hsieh
Original Assignee
Actherm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actherm Inc filed Critical Actherm Inc
Priority to TW097139825A priority Critical patent/TWI385384B/en
Publication of TW201017160A publication Critical patent/TW201017160A/en
Application granted granted Critical
Publication of TWI385384B publication Critical patent/TWI385384B/en

Links

Description

流體檢測試片及流體檢測方法Fluid testing test piece and fluid detecting method

本發明係關於一種流體檢測試片,特別是一種有關於用於定量檢測的流體檢測試片。The present invention relates to a fluid test strip, and more particularly to a fluid test strip for quantitative detection.

在生物檢體的定量的習知技術中,常利用免疫分子具有專一性辨識能力的特定來進行測量,例如傳統的酵素連結免疫吸附測試(enzyme linked immunolsorbent assay,ELISA),多在96孔盤(96-well plate)中操作,並藉由偵測最終酵素反應所發出之訊號,回推待測物質之濃度。但是由於此種測試,為了要避免免疫分子與待測物中包含的其他雜質進行非專一性結合,所以必須在各個反應階段加入清洗的步驟,藉以將未與待測物或是其他免疫分子結合之反應試劑自96孔盤中清除,以免造成過多的酵素留置於各孔位(well)中所造成的偽陽性訊號,導致測試失敗。In the conventional technique of quantification of biological samples, the specificity of the specificity of the immune molecule is often used for measurement, such as a conventional enzyme linked immunosorbent assay (ELISA), which is mostly in a 96-well plate ( The 96-well plate is operated and the concentration of the substance to be tested is pushed back by detecting the signal from the final enzyme reaction. However, due to this test, in order to avoid non-specific binding of immune molecules to other impurities contained in the analyte, it is necessary to add a washing step at each reaction stage so as not to combine with the analyte or other immune molecules. The reagents were removed from the 96-well plate to avoid false positive signals caused by excessive enzymes remaining in the wells, resulting in a test failure.

由於機電技術的發展,已有利用具有微流道結構之測試試片進行免疫偵測,簡化上述傳統測試方法中於各步驟後進行清洗等繁瑣流程。然目前已知的測試試片,在進行偵測時仍需將反應試劑或反應所需之受質(substrate)以額外添加的方式加入測試試片中。此種反應試劑或受質與檢測試片分離存放,於偵測時再行添加的方式乃是起因於其所需的反應試劑或受質,在室溫中無法長期存放,需保存於特定環境中(如冷藏或避光保存),以避免因反應物變質所導致的測試誤差。故此種檢測試片在操作及保存上仍多有所不便。Due to the development of electromechanical technology, the test strips with micro-channel structure have been used for immunodetection, simplifying the cumbersome process of cleaning in each of the above-mentioned conventional test methods. However, the currently known test strips still need to add the reagents required for the reaction reagent or reaction to the test piece in an additional manner when detecting. The reagent or the substrate is separated from the test piece and stored in the detection process because of the required reagent or substrate, which cannot be stored for a long time at room temperature and needs to be stored in a specific environment. Medium (such as refrigerated or protected from light) to avoid test errors caused by deterioration of the reactants. Therefore, such test strips are still inconvenient in operation and storage.

此外習知具有流道或微流道結構的流體檢測試片,因流道周圍並非吸水材質,且待測流體多為含有如蛋白質或是醣類等黏滯度高之組成物,所以當待測流體流過後,會在流道上殘留,使得待測流體無法完全反應,如此一來,不僅造成待測流體的浪費,更可能造成最終測試結果的誤差。In addition, it is known that a fluid detecting test piece having a flow path or a micro flow path structure is not a water absorbing material around the flow path, and the fluid to be tested is a composition having a high viscosity such as protein or sugar, so it is to be treated. After the fluid is measured, it will remain on the flow channel, so that the fluid to be tested cannot be completely reacted. As a result, not only the waste of the fluid to be tested is caused, but also the error of the final test result is more likely.

此外,習知具有微流道結構的流體檢測試片在流體傳送方面,則是利用微流道結構產生的毛細現象,將流體經過流道被動傳送至反應偵測區域;另一種方式則是在注入待測流體時即利用加壓等方式,給予流體一驅動力,使得流體可主動通過流道,到達反應偵測區域。但是無論是上述任一種方式,待測流體注入流道後常常產生大小不一的氣泡使得流道阻塞,造成實際測量上之誤差,甚至致使測試失敗。In addition, in the fluid transfer test piece, the fluid detecting test piece having the micro-channel structure is a capillary phenomenon generated by the micro-channel structure, and the fluid is passively transmitted to the reaction detecting area through the flow path; the other way is When the fluid to be tested is injected, a driving force is given to the fluid by means of pressurization or the like, so that the fluid can actively pass through the flow path to reach the reaction detecting area. However, in either of the above manners, after the fluid to be tested is injected into the flow channel, bubbles of different sizes are often generated to block the flow path, causing an error in actual measurement, and even causing the test to fail.

為克服上述缺點,本發明提供一種流體檢測試片,包含有具有流道的基板。流道上設置有依序連接之第一流體區、第二流體區與第三流體區,其中第一流體區係供流體之注入。此外,流道中具有第一抗體、醣類材料、過氧化物脢、第二抗體、發光劑與受質反應試劑。第一抗體位於第一流體區中,用於辨識待測物質。醣類材料及過氧化物脢則位於第一流體區或第二流體區中。第二抗體則是固定(immobilized)於第二流體區中,且亦辨識同一待測物質,又第二抗體及第一抗體係辨識相異之抗原決定位置(epitope)。發光劑與受質反應試劑係共同位於第三流體區中,受質反應試劑包含有一醣氧化脢。藉此,當包含有待測物質之流體注入流道後,第一抗體、醣類材料及過氧化物脢係隨著流體流動,部份之過氧化物脢會與第一抗體、待測物質及第二抗體結合並留置於第二流體區中,未結合之過氧化物脢則隨流體流至該第三流體區,且醣氧化脢會催化流至第三流體區之醣類材料進行氧化反應,並產生出過氧化氫(H2 O2 ),且發光劑會受到流至第三流體區的過氧化物脢催化與過氧化氫進行反應,並產生一光學訊號。In order to overcome the above disadvantages, the present invention provides a fluid detecting test piece comprising a substrate having a flow path. The flow path is provided with a first fluid zone, a second fluid zone and a third fluid zone which are sequentially connected, wherein the first fluid zone is for fluid injection. Further, the flow path has a first antibody, a saccharide material, a peroxide oxime, a second antibody, a luminescent agent, and a substrate reaction reagent. The first antibody is located in the first fluid zone for identifying the substance to be tested. The saccharide material and the peroxide enthalpy are located in the first fluid zone or the second fluid zone. The second antibody is immobilized in the second fluid zone and also identifies the same test substance, and the second antibody and the first antibody system recognize distinct epitopes. The luminescent agent and the substrate reaction reagent are co-located in the third fluid zone, and the host reagent comprises a saccharide cerium oxide. Thereby, after the fluid containing the substance to be tested is injected into the flow channel, the first antibody, the saccharide material and the peroxide lanthanum flow with the fluid, and some of the peroxide oxime is combined with the first antibody, the test substance and The second antibody binds and remains in the second fluid zone, and the unbound peroxide oxime flows with the fluid to the third fluid zone, and the saccharide ruthenium catalyzes the oxidation of the saccharide material to the third fluid zone for oxidation reaction. And hydrogen peroxide (H 2 O 2 ) is generated, and the luminescent agent is reacted with hydrogen peroxide by the peroxide ruthenium flowing to the third fluid region to generate an optical signal.

因此,本發明之主要目的,係提供一種流體檢測試片,由於具有所有反應所需的試劑及材料,無須經由繁瑣之操作步驟即可直接測量最終反應訊號進行定量偵測。Therefore, the main object of the present invention is to provide a fluid detecting test piece. Since all the reagents and materials required for the reaction are provided, the final reaction signal can be directly measured for quantitative detection without cumbersome operation steps.

本發明之另一目的,係提供一種流體檢測試片,其中反應所須的試劑與材料,在反應前係以乾燥方式留存於試片中,故可長期保存,不致因試劑變質而導致測試誤差。Another object of the present invention is to provide a fluid detecting test piece in which the reagents and materials required for the reaction are retained in the test piece in a dry manner before the reaction, so that the test can be stored for a long period of time without causing test errors due to deterioration of the reagent. .

本發明亦提供一種流體檢測方法,主要包含下列步驟。(1)提供具有待測物的流體。(2)提供一基板,基板包含至少流道,而流道包含依序連接之第一流體區、第二流體區與第三流體區,第一流體區係供流體之注入。基板上進一步包含有第一抗體,位於第一流體區中,用於辨識該流體內之該待測物質;醣類材料,位於第一流體區或第二流體區中;過氧化物脢,位於第一流體區或第二流體區中;第二抗體,固定於第二流體區中,且亦辨識同一待測物質,而第二抗體及第一抗體係辨識相異之抗原決定位置;以及發光劑與受質反應試劑,位於第三流體區中,受質反應試劑包含有醣氧化脢。(3)將流體加至流道之第一流體區,使第一抗體、醣類材料及該過氧化物脢隨著流體流動。(4)使待測物質與第一抗體、第二抗體及部份之過氧化物脢結合並留置於第二流體區中,使流體帶著醣類材料、未結合之第一抗體及過氧化物脢流至第三流體區,使醣類材料受到醣氧化脢之催化進行氧化反應,並產生出過氧化氫,發光劑會受到流至第三流體區的過氧化物脢催化與過氧化氫進行反應,並產生一光學訊號。(5)偵測產生之光學訊號。The invention also provides a fluid detection method, which mainly comprises the following steps. (1) Providing a fluid having a substance to be tested. (2) providing a substrate, the substrate comprising at least a flow channel, and the flow channel comprises a first fluid zone, a second fluid zone and a third fluid zone sequentially connected, wherein the first fluid zone is for fluid injection. The substrate further comprises a first antibody located in the first fluid region for identifying the substance to be tested in the fluid; a saccharide material located in the first fluid region or the second fluid region; In the first fluid zone or the second fluid zone; the second antibody is fixed in the second fluid zone and also identifies the same substance to be tested, and the second antibody and the first antibody system recognize different antigenic determining positions; and illuminate The reagent and the reagent for the reaction are located in the third fluid zone, and the reagent for the reaction contains glucosinolate. (3) A fluid is applied to the first fluid zone of the flow channel such that the first antibody, the saccharide material, and the peroxide enthalpy flow with the fluid. (4) combining the test substance with the first antibody, the second antibody and a part of the peroxide oxime and leaving it in the second fluid zone, the fluid carrying the saccharide material, the unbound primary antibody and the peroxidation The enthalpy flows to the third fluid zone, so that the saccharide material is oxidized by the saccharide ruthenium ruthenium, and hydrogen peroxide is generated, and the illuminant is catalyzed by the ruthenium hydride catalyzed by the third fluid region. The reaction is carried out and an optical signal is generated. (5) Detecting the generated optical signal.

因此,本發明之另一目的,係提供一種流體檢測方法,由於具有所有反應所需的試劑及材料,無須經由繁瑣之操作步驟即可直接測量最終反應訊號進行定量偵測。本發明之再一目的,係提供一種流體檢測方法,其中反應所須的試劑與材料,在反應前係以乾燥方式留存於試片中,故可長期保存,不致因試劑變質而導致測試誤差。Therefore, another object of the present invention is to provide a fluid detecting method which can directly measure the final reaction signal for quantitative detection without cumbersome steps by having all the reagents and materials required for the reaction. Still another object of the present invention is to provide a fluid detecting method in which a reagent and a material required for the reaction are retained in a test piece in a dry manner before the reaction, so that it can be stored for a long period of time without causing a test error due to deterioration of the reagent.

由於本發明係揭露一種流體檢測試片及其測試方法,其中所利用化學原理及生物檢測技術,已為相關技術領域具有通常知識者所能明瞭,故以下文中之說明,不再作完整描述。同時,以下文中所對照之圖式,係表達與本發明特徵有關之示意,並未亦不需要依據實際情形完整繪製,合先敘明。Since the present invention discloses a fluid detecting test piece and a test method thereof, the chemical principle and the biological detecting technology utilized by the present invention are well known to those skilled in the relevant art, and therefore, the description below will not be completely described. At the same time, the drawings in the following texts are indicative of the features related to the features of the present invention, and are not required to be completely drawn according to the actual situation.

請參考第1A圖,為本發明之第一較佳實施例流體檢測試片之示意圖。流體檢測試片1包含有基板10,基板10包含有流道11。流道11上設置有依序連接之第一流體區111、第二流體區112與第三流體區113,其中第一流體區111係供流體之注入。Please refer to FIG. 1A, which is a schematic diagram of a fluid detecting test piece according to a first preferred embodiment of the present invention. The fluid detecting test piece 1 includes a substrate 10 including a flow path 11. The flow path 11 is provided with a first fluid zone 111, a second fluid zone 112 and a third fluid zone 113 which are sequentially connected, wherein the first fluid zone 111 is for fluid injection.

請繼續參考第1B圖,為本發明第一較佳實施例流體檢測試片流道中反應材料分佈示意圖。第一流體區111中具有第一抗體1111、醣類材料1112及過氧化物脢1113。第二流體區112中具有第二抗體1121,而第二抗體1121是固定在第二流體區112之中。又,第一抗體1111與第二抗體1121都是辨識流體中的同一種待測物質1101,但是第一抗體1111與第二抗體1121是各自辨識待測物質1101上不同的抗原決定位置。所以在第一抗體1111和第二抗體1121的選用上,兩者均可為單株抗體(mAb)或多株抗體(pAb),只需要第一抗體1111和第二抗體1121是一組抗體配對(antibody pair),在進行抗原辨識時,不致發生互相干擾的狀況即可。第三流體區113之中則具有發光劑1131與受質反應試劑1132,受質反應試劑1132包含有醣氧化脢1133。其中,過氧化物脢1113可以是辣根過氧化物脢(HRP,Horseradish Peroxidase)、抗壞血酸過氧化物脢(AP,Ascorbate Peroxidase)或是過氧化氫脢(hydrogen peroxidase)。在較佳的實施狀態中,發光劑1131是用3-氨基鄰苯二甲醯肼(5-Amino-2,3-dihydro-1,4-phthalazinedione),而醣類材料1112則可為葡萄糖,於此同時,醣氧化脢1133則是選用葡萄糖氧化脢。Please refer to FIG. 1B for a schematic diagram of the distribution of reactive materials in the flow path of the fluid detecting test piece according to the first preferred embodiment of the present invention. The first fluid region 111 has a first antibody 1111, a saccharide material 1112, and a peroxide 脢 1113. The second fluid region 112 has a second antibody 1121 therein, and the second antibody 1121 is immobilized in the second fluid region 112. Further, the first antibody 1111 and the second antibody 1121 are both the same test substance 1101 in the identification fluid, but the first antibody 1111 and the second antibody 1121 are each different in determining the antigen-determining position on the test substance 1101. Therefore, in the selection of the first antibody 1111 and the second antibody 1121, both of them can be monoclonal antibodies (mAbs) or multiple antibodies (pAbs), and only the first antibody 1111 and the second antibody 1121 are required to be a pair of antibodies. (antibody pair), in the case of antigen recognition, it is not necessary to interfere with each other. The third fluid region 113 has a luminescent agent 1131 and a dye-reactive reagent 1132, and the host-reactive reagent 1132 contains glucosinolate 1133. The peroxide 脢 1113 may be HRP (Horseradish Peroxidase), Ascorbate Peroxidase (AP), or Hydrogen Peroxidase (hydrogen peroxidase). In a preferred embodiment, the illuminant 1131 is 3-aminohydrophthalic acid (5-Amino-2,3-dihydro-1,4-phthalazinedione), and the saccharide material 1112 is glucose. At the same time, the sugar bismuth oxide 1133 is selected from glucose cerium oxide.

請繼續參考第1C至第1E圖,為本發明第一較佳實施例流體檢測試片流道中反應材料在不同反應階段的分佈示意圖。首先請參考第1C圖,當含有待測物質1101的流體注入流道11之後,第一抗體1111會辨識到待測物質1101,並與其做結合。此外,由於第一抗體1111、醣類材料1112及過氧化物脢1113並未固定於第一流體區中,所以此時第一抗體1111、與第一抗體1111結合之待測物質1101、過氧化物脢1113,及醣類材料1112會隨著流體一起繼續往第二流體區112流動。Please refer to FIG. 1C to FIG. 1E as a schematic diagram showing the distribution of the reaction materials in the flow paths of the fluid detecting test piece in different reaction stages according to the first preferred embodiment of the present invention. First, referring to FIG. 1C, after the fluid containing the substance to be tested 1101 is injected into the flow path 11, the first antibody 1111 recognizes and combines with the substance 1101 to be tested. In addition, since the first antibody 1111, the saccharide material 1112, and the peroxide 脢1113 are not fixed in the first fluid region, the first antibody 1111 and the first antibody 1111 are combined with the test substance 1101 and peroxidized. The substance 1113, and the saccharide material 1112, continue to flow along the fluid to the second fluid zone 112.

請繼續參考第1D圖,當流體流至第二反應區112之後,第二抗體1121會與待測物質1101結合。此時,由於第二抗體1121是固定在第二流體區112之中,所以會將已經與待測物質1101結合的第一抗體1111以及在第一抗體1111之上的過氧化物脢1113一併留置於第二流體區112之中;而此時亦流至第二流體區112的醣類材料1112則會和未與待測物質1101結合的第一抗體1111和過氧化物脢1113則會隨著流體繼續向第三流體區113流動。Referring to FIG. 1D, after the fluid flows to the second reaction zone 112, the second antibody 1121 will bind to the substance to be tested 1101. At this time, since the second antibody 1121 is fixed in the second fluid region 112, the first antibody 1111 which has been bound to the test substance 1101 and the peroxide 脢 1113 above the first antibody 1111 are combined. The saccharide material 1112 flowing to the second fluid region 112 at this time will be followed by the first antibody 1111 and the peroxide 脢1113 which are not combined with the substance to be tested 1101. The fluid continues to flow to the third fluid zone 113.

請繼續參考第1E圖,醣類材料1112和未與第一抗體1111、第二抗體1112以及待測物質1101結合留置在第二流體區112之中的過氧化物脢1113會流至第三流體區113。此時,醣類材料1112會與已經存在於第三流體區113之中的醣氧化脢1133進行氧化反應,產生出過氧化氫,而產生出的過氧化氫以及發光劑1131會受到流至第三反應區113的過氧化物脢1113進行催化,產生光學訊號。此時,可藉由偵測光學訊號的強度,推算出參與反應的酵素濃度,亦即可藉由偵測光學訊號的強度推算出有多少過氧化物脢1113流至第三流體區113,且由於在製作流體檢測試片1之時,要添加的過氧化物脢1113含量係為一已知的固定值,所以留置於第二流體區112之中的過氧化物脢1113其濃度亦可藉由兩者簡單相減後推算得知。最後,利用已知的留置於第二流體區112之中的過氧化物脢1113的濃度,可再推算出流體中所含有的待測物質1101的濃度,以達到定量檢測的目的。Continuing to refer to FIG. 1E, the saccharide material 1112 and the peroxide 脢 1113 not in contact with the first antibody 1111, the second antibody 1112, and the test substance 1101 in the second fluid region 112 flow to the third fluid. District 113. At this time, the saccharide material 1112 is oxidized with the glucoside ruthenium 1133 already present in the third fluid region 113 to generate hydrogen peroxide, and the generated hydrogen peroxide and the illuminant 1131 are subjected to the flow. The peroxide 脢 1113 of the three reaction zone 113 is catalyzed to produce an optical signal. At this time, by detecting the intensity of the optical signal, the concentration of the enzyme involved in the reaction can be estimated, and the amount of the peroxide 脢 1113 flowing to the third fluid region 113 can be estimated by detecting the intensity of the optical signal, and Since the content of the peroxide 脢 1113 to be added is a known fixed value at the time of preparation of the fluid test strip 1, the concentration of the peroxide 脢 1113 remaining in the second fluid region 112 can also be borrowed. It is estimated by simple subtraction between the two. Finally, the concentration of the test substance 1101 contained in the fluid can be further calculated by using the known concentration of the peroxide 脢 1113 remaining in the second fluid region 112 for the purpose of quantitative detection.

在未反應前,第一抗體1111與過氧化物脢1113兩者的結合型態可以是直接形成共軛結合(conjugation);或是第一抗體1111上共軛結合有生物素(Biotin),而過氧化物脢1113則與親和素(Avidin)共軛結合,利用生物素與親和素會強力結合成一錯合物(AB complex)的特性,使得在進行反應時,當有第一抗體1111留置於第二流體區112時,也會將部份的過氧化物脢1113固定留置於第二流體區112。上述之親合素可以是卵白素(Avidin)、鏈黴親合素(Streptavidin),或是中性鏈親和素(NeutrAvidin)。Before the unreacted, the binding form of the first antibody 1111 and the peroxide 脢1113 may be direct formation of conjugation; or the first antibody 1111 is conjugated with biotin (Biotin), and The peroxide 脢1113 is conjugated to avidin (Avidin), and the biotin and avidin are strongly combined to form a complex of AB complex, so that when the reaction is carried out, when the first antibody 1111 is left In the second fluid zone 112, a portion of the peroxide crucible 1113 is also retained in the second fluid zone 112. The avidin described above may be Avidin, Streptavidin, or NeutrAvidin.

請繼續參考第1F圖至第1H圖,為本發明第一較佳實施例流體檢測試片流道中反應材料其他方式分佈示意圖。為達成本發明的定量檢測之目的,流體檢測試片1中醣類材料1112及過氧化物脢1113在流道11中的分佈方式除如第1B圖所示之均存在於第一流道111的分佈方式之外,還可以分佈在第二流道112之中。Please refer to FIG. 1F to FIG. 1H for a schematic diagram showing other modes of distribution of reactive materials in the flow path of the fluid detecting test piece according to the first preferred embodiment of the present invention. For the purpose of quantitative detection of the present invention, the distribution of the saccharide material 1112 and the peroxide 脢1113 in the fluid detecting test piece 1 in the flow path 11 is present in the first flow path 111 except as shown in FIG. 1B. In addition to the distribution mode, it may also be distributed in the second flow path 112.

首先,請參考第1F圖,第一抗體1111和過氧化脢1113位於第一流體區111中,而醣類材料1112則位於第二流體區112中,此時,第一抗體1111與過氧化物脢1113兩者的結合型態方式則與上述之直接共軛結合,或是利用生物素與親和素結合成一錯合物(AB complex)的特性,第一抗體1111與過氧化物脢1113各自以結合有生物素與親和素的方式存在。流道11中其餘之反應材料第二抗體1121、發光劑1131、受質反應試劑1132,及醣氧化脢1133的分佈方式則與第1B圖中相同。採用此種分佈之設置狀態,在流體流過第二流體區112後,醣類材料1112一樣會隨著流體流至第三流體區113,故其後之各反應階段中反應材料的流動分佈情形及所進行之反應則與第1C圖至第1E圖所示,在此不再重複贅述。First, referring to FIG. 1F, the first antibody 1111 and the ruthenium peroxide 1113 are located in the first fluid region 111, and the saccharide material 1112 is located in the second fluid region 112. At this time, the first antibody 1111 and the peroxide The binding mode of 脢1113 is directly conjugated to the above, or the combination of biotin and avidin is formed into a complex of AB complex, and the first antibody 1111 and the peroxide 脢1113 are respectively It exists in a way that combines biotin and avidin. The distribution pattern of the remaining reaction material second antibody 1121, illuminant 1131, substrate reaction reagent 1132, and glucoside ruthenium oxide 1133 in the flow channel 11 is the same as in the first panel. With this distributed state of arrangement, after the fluid flows through the second fluid zone 112, the sugar material 1112 will flow with the fluid to the third fluid zone 113, so the flow distribution of the reactive material in each subsequent reaction stage. And the reactions performed are shown in FIGS. 1C to 1E, and the description thereof will not be repeated here.

請再參考第1G圖,此種分佈設置下,第一抗體1111是位於第一流體區111中,而過氧化脢1113與醣類材料1112則位於第二流體區112中。而在第1H圖所代表的分佈方式,則是第一抗體1111與醣類材料1112位於第一流體區111、過氧化脢1113則位於第二流體區112中。流道11中其餘之反應材料第二抗體1121、發光劑1131、受質反應試劑1132,及醣氧化脢1133的分佈方式則與第1B圖中相同,且其後之各反應階段中反應材料的流動分佈情形及所進行之反應則與第1C圖至第1E圖所示,在此不再重複贅述。Referring again to FIG. 1G, in such a distribution, the first antibody 1111 is located in the first fluid zone 111, and the ruthenium peroxide 1113 and the saccharide material 1112 are located in the second fluid zone 112. In the distribution pattern represented by the 1H diagram, the first antibody 1111 and the saccharide material 1112 are located in the first fluid region 111, and the ruthenium peroxide 1113 is located in the second fluid region 112. The remaining reaction materials of the second antibody 1121, the illuminant 1131, the substrate reaction reagent 1132, and the glucosinolate 1133 in the flow channel 11 are distributed in the same manner as in FIG. 1B, and the reaction materials in the subsequent reaction stages are The flow distribution situation and the reaction performed are shown in FIGS. 1C to 1E, and the description thereof will not be repeated here.

請繼續參考第11圖,為第1A圖沿AA連線的剖面示意圖。如圖所示,在第一流體區111之底部包含有纖維層1110,而第一抗體(1111,第1B圖)係形成於纖維層1110之中,如此使得在流體注入第一流體區111之後,第一抗體(1111,第1B圖)會隨流體一起流至第二流體區112。而在第二流體區112與第三流體區113的底部各自具有第二硝化纖維層1120與第三硝化纖維層1130。第二抗體(1121,第1B圖)係固定於第二硝化纖維層1120之中,而受質反應試劑(1132,第1B圖)係形成於第三硝化纖維層1130中。Please continue to refer to Figure 11 for a cross-sectional view of Figure 1A along AA. As shown, a fibrous layer 1110 is included at the bottom of the first fluid zone 111, and a first antibody (1111, FIG. 1B) is formed in the fibrous layer 1110 such that after the fluid is injected into the first fluid zone 111 The first antibody (1111, Figure 1B) will flow with the fluid to the second fluid zone 112. The second nitrocellulose layer 1120 and the third nitrocellulose layer 1130 are each provided at the bottom of the second fluid zone 112 and the third fluid zone 113. The second antibody (1121, Fig. 1B) is fixed in the second nitrocellulose layer 1120, and the host reaction reagent (1132, Fig. 1B) is formed in the third nitrocellulose layer 1130.

上述的第二硝化纖維層1120與第三硝化纖維層1130可以是以一層硝化纖維膜(NC membrane)的形式鋪設在第二流體區112以及第三流體區113的底部。The second nitrocellulose layer 1120 and the third nitrocellulose layer 1130 may be laid in the form of a layer of nitrocellulose membrane (NC membrane) at the bottom of the second fluid zone 112 and the third fluid zone 113.

另一種較佳的製作形式,則可以將硝化纖維溶液以澆注(casting)的方式,澆注在第二流體區112以及第三流體區113的底部,再經過風乾或是冷凍乾燥的步驟,藉此各自形成具有中空網狀構型的第二硝化纖維層1120與第三硝化纖維層1130。此外,為了降低流道與流體之間的毛細作用所造成的影響,此種以澆注方式所製成之流道並非習知技術所謂的微流道,且第二流體區112與第三流體區113的最小寬度較佳為0.3 mm,而基板10則可採用生物相容材料。為達較佳的澆注效果,流道11的表面粗糙度較佳範圍(Ra值)在3微米至50微米之間,而第二硝化纖維層1120的平均厚度等於第三硝化纖維層1130厚度。此外,流道11可進一步包括第四流體區(未圖示),第四流體區之底部亦形成有硝化纖維層,供多餘流體之貯存,且此硝化纖維層具有中空網狀構型。In another preferred form, the nitrocellulose solution can be cast in the second fluid zone 112 and the bottom of the third fluid zone 113 in a casting manner, followed by air drying or freeze drying. Each of the second nitrocellulose layer 1120 and the third nitrocellulose layer 1130 having a hollow network configuration is formed. In addition, in order to reduce the influence of capillary action between the flow path and the fluid, such a flow path made by casting is not a so-called micro flow path of the prior art, and the second fluid zone 112 and the third fluid zone The minimum width of 113 is preferably 0.3 mm, while the substrate 10 can be made of a biocompatible material. For better casting, the surface roughness of the flow path 11 is preferably in the range of 3 to 50 microns, and the average thickness of the second nitrocellulose layer 1120 is equal to the thickness of the third nitrocellulose layer 1130. Further, the flow path 11 may further include a fourth fluid zone (not shown), and a bottom of the fourth fluid zone is also formed with a layer of nitrocellulose for storage of excess fluid, and the nitrocellulose layer has a hollow network configuration.

上述之硝化纖維溶液係將硝化纖維粉末與包含有酯類及酮類溶劑混合後製成,而硝化纖維粉末與酯類及酮類溶劑所混合的較佳體積比例為1:9。又,在此種以澆注方式形成硝化纖維層的狀態下,可在第二硝化纖維層1120與第三硝化纖維層1130乾燥後,將第二抗體1121以溶液的方式注入第二硝化纖維層1120,再經過風乾或冷凍乾燥的過程,使第二抗體1121以粉末狀的方式留存於第二硝化纖維層1120之中。The above nitrocellulose solution is prepared by mixing nitrocellulose powder with a solvent containing an ester and a ketone, and a preferred volume ratio of the nitrocellulose powder to the ester and the ketone solvent is 1:9. Further, in the state in which the nitrocellulose layer is formed by casting, the second nitrocellulose layer 1120 and the third nitrocellulose layer 1130 are dried, and the second antibody 1121 is injected into the second nitrocellulose layer 1120 as a solution. Then, the second antibody 1121 is retained in the second nitrocellulose layer 1120 in a powder form by air drying or freeze drying.

除上述先形成硝化纖維層於流體區底部後再將第二抗體1121及受質反應試劑形成於其中的方式之外,還可將第二抗體1121以溶液的方式注入預 先製備好的硝化纖維溶液,混合均勻後,再澆注於第二流體區112的底部,再經風乾或冷凍乾燥過程,同時將硝化纖維溶液形成第二硝化纖維層1120及第二抗體1121以粉末狀的方式留存其中。In addition to the above manner of forming the nitrocellulose layer at the bottom of the fluid region and then forming the second antibody 1121 and the substrate reaction reagent therein, the second antibody 1121 may be injected as a solution. The prepared nitrocellulose solution is firstly mixed, and then poured into the bottom of the second fluid zone 112, and then air-dried or freeze-dried, and the nitrocellulose solution is formed into the second nitrocellulose layer 1120 and the second antibody 1121 as a powder. The way is retained.

此外,受質反應試劑1132形成於第三硝化纖維層1130中的方式亦與上述第二抗體1121形成於第二硝化纖維層1120的方式大致相同,可採用先形成第三硝化纖維層1130後再注入受質反應試劑並乾燥,或是與硝化纖維溶液混合後一同注入第三流體區113底部乾燥成型的兩種方式,故在此不再重複贅述。In addition, the manner in which the dye-reactive reagent 1132 is formed in the third nitrocellulose layer 1130 is also substantially the same as the manner in which the second antibody 1121 is formed on the second nitrocellulose layer 1120, and the third nitrocellulose layer 1130 may be formed first. The dyed reagent is injected and dried, or mixed with the nitrocellulose solution and injected into the bottom of the third fluid zone 113 to form a dry form. Therefore, the description thereof will not be repeated here.

除上述的第一較佳實施例之外,本發明亦提供一種流體檢測方法,如下之第二較佳實施例中所述,其中檢測方法中所採用之檢測試片,其構造特徵與第一較佳實施例中大致相同,故不再重複贅述,且其中提及之檢測試片元件編號,請參考第1B圖至第1H圖。In addition to the first preferred embodiment described above, the present invention also provides a fluid detecting method, as described in the second preferred embodiment, wherein the detecting test piece used in the detecting method has the structural features and the first The preferred embodiments are substantially the same, so the description will not be repeated, and the number of the test strip components mentioned therein can be referred to FIGS. 1B to 1H.

請參考第2圖,為本發明第二較佳實施例流體檢測方法之流程示意圖。流體檢測方法2包含以下步驟:Please refer to FIG. 2, which is a schematic flow chart of a fluid detecting method according to a second preferred embodiment of the present invention. The fluid detection method 2 comprises the following steps:

步驟21:提供一流體,流體包含有待測物質1101,請參考第1B圖。Step 21: Provide a fluid containing the substance to be tested 1101, please refer to Figure 1B.

步驟22:提供基板10,基板10包含至少有流道11。流道11包含依序連接之第一流體區111、第二流體區112與第三流體區113,第一流體區111係供流體之注入。第一流體區111中具有第一抗體1111。第二抗體區112中具有第二抗體1121,且第二抗體1121是固定在第二抗體區112之中。又,第一抗體1111與第二抗體1121都是辨識流體中的同一種待測物質1101,但是第一抗體1111與第二抗體1121是各自辨識待測物質1101上不同的抗原決定位置。所以在第一抗體1111和第二抗體1121的選用上,兩者均可為單株抗體或多株抗體,只需要第一抗體1111和第二抗體1121是一組抗體配對,在進行抗原辨識時,不致發生互相干擾的狀況即可。第三流體區113之中則具有發光劑1131與受質反應試劑1132,受質反應試劑1132包含有醣氧化脢1133。其中,過氧化物脢1113可以是辣根過氧化物脢、抗壞血酸過氧化物脢或是過氧化氫脢。在較佳的實施狀態中,發光劑1131是用3-氨基鄰苯二甲醯肼,而醣類材料1112則可為葡萄糖,於此同時,醣氧化脢1133則是選用葡萄糖氧化脢。此外,醣類材料1112及過氧化物脢1113在流道11的各種分佈情形,則如第一較佳實施例中所述(請參考第1B圖、第1F圖、第1G圖及第1H圖)。Step 22: Providing a substrate 10 comprising at least a flow channel 11. The flow path 11 includes a first fluid zone 111, a second fluid zone 112 and a third fluid zone 113 which are sequentially connected, and the first fluid zone 111 is for fluid injection. The first fluid region 111 has a first antibody 1111 therein. The second antibody region 112 has a second antibody 1121 therein, and the second antibody 1121 is immobilized in the second antibody region 112. Further, the first antibody 1111 and the second antibody 1121 are both the same test substance 1101 in the identification fluid, but the first antibody 1111 and the second antibody 1121 are each different in determining the antigen-determining position on the test substance 1101. Therefore, in the selection of the first antibody 1111 and the second antibody 1121, both of them can be single antibody or multiple antibodies, and only the first antibody 1111 and the second antibody 1121 are a pair of antibodies, and when antigen identification is performed. It is not necessary to interfere with each other. The third fluid region 113 has a luminescent agent 1131 and a dye-reactive reagent 1132, and the host-reactive reagent 1132 contains glucosinolate 1133. Among them, the peroxide 脢 1113 may be horseradish peroxide 脢, ascorbyl peroxide or guanidine hydroperoxide. In a preferred embodiment, the illuminant 1131 is 3-aminophthalic acid, and the saccharide material 1112 is glucose. Meanwhile, the glucoside ruthenium 1133 is glucose ruthenium oxide. In addition, the various distributions of the saccharide material 1112 and the peroxide 脢1113 in the flow channel 11 are as described in the first preferred embodiment (please refer to FIG. 1B, FIG. 1F, FIG. 1G, and FIG. 1H). ).

步驟23:將流體加至流道11之第一流體區111。流體會沿著流道11依序由第一流體區111流經第二流體區112,流至第三流體區113,並藉使存在於流道11中的第一抗體1111、醣類材料1112及過氧化物脢1113隨著流體流動。Step 23: Adding fluid to the first fluid zone 111 of the flow channel 11. The fluid will sequentially flow from the first fluid zone 111 to the third fluid zone 112 along the flow path 11 to the third fluid zone 113, and the first antibody 1111 and the saccharide material 1112 present in the flow channel 11 And the peroxide 脢 1113 flows with the fluid.

步驟24:待測物質1101會隨流體流至第二流體區112,使待測物質1101與第一抗體1111、第二抗體1121及部份之過氧化物脢1113結合並一同留置於第二流體區112中。流體繼續帶著醣類材料1112、未結合之第一抗體1111及過氧化物脢1113流至第三流體區113。在第三流體區中醣類材料1112受到醣氧化脢1133之催化進行氧化反應,並產生出過氧化氫。而發光劑1131會受到流至第三流體區113的過氧化物脢1113催化與過氧化氫進行反應,並產生一光學訊號。Step 24: The test substance 1101 will flow with the fluid to the second fluid region 112, and the test substance 1101 is combined with the first antibody 1111, the second antibody 1121 and a portion of the peroxide 脢 1113 and left together in the second fluid. In area 112. The fluid continues to flow to the third fluid zone 113 with the saccharide material 1112, the unbound primary antibody 1111, and the peroxide 脢 1113. In the third fluid zone, the saccharide material 1112 is oxidized by the saccharide ruthenium hydride 1133 and produces hydrogen peroxide. The illuminant 1131 is catalyzed by the peroxide 脢 1113 flowing to the third fluid region 113 to react with hydrogen peroxide and generate an optical signal.

步驟25:偵測由步驟24產生之光學訊號。此時,可藉由偵測光學訊號的強度,推算出參與反應的酵素濃度,亦即可藉由偵測光學訊號的強度推算出有多少過氧化物脢1113流至第三流體區113,且由於在製作流體檢測試片1之時,要添加的過氧化物脢1113含量係為一已知的固定值,所以留置於第二流體區112之中的過氧化物脢1113其濃度亦可藉由兩者簡單相減後推算得知。最後,利用已知的留置於第二流體區112之中的過氧化物脢1113的濃度,可再推算出流體中所含有的待測物質1101的濃度,以達到定量檢測的目的。Step 25: Detect the optical signal generated by step 24. At this time, by detecting the intensity of the optical signal, the concentration of the enzyme involved in the reaction can be estimated, and the amount of the peroxide 脢 1113 flowing to the third fluid region 113 can be estimated by detecting the intensity of the optical signal, and Since the content of the peroxide 脢 1113 to be added is a known fixed value at the time of preparation of the fluid test strip 1, the concentration of the peroxide 脢 1113 remaining in the second fluid region 112 can also be borrowed. It is estimated by simple subtraction between the two. Finally, the concentration of the test substance 1101 contained in the fluid can be further calculated by using the known concentration of the peroxide 脢 1113 remaining in the second fluid region 112 for the purpose of quantitative detection.

此外,根據本發明之流體檢測方法,其中第一抗體1111與過氧化物脢1113的結合方式與較佳選用種類、各流體區的構造組成、硝化纖維層之構型、形成方式、使用之硝化纖維溶液之成份與較佳比例、各項反應材料之組成及形成方式,均與前述之第一較佳實施例相同,在此不再重複贅述。Further, according to the fluid detecting method of the present invention, the combination of the first antibody 1111 and the peroxide 脢1113 and the preferred type, the structural composition of each fluid region, the configuration of the nitrocellulose layer, the formation mode, and the nitrification used The composition and the preferred ratio of the fiber solution, the composition and the formation manner of each of the reaction materials are the same as those of the first preferred embodiment described above, and the detailed description thereof will not be repeated here.

以上所述僅為本發明較佳實施例而已,並非用以限定本發明申請專利權利;同時以上的描述對於熟之本技術領域之專門人士應可明瞭與實施,因此其他未脫離本發明所揭示之精神下所完成的等效改變或修飾,均應包含於下述之申請專利範圍。The above description is only for the preferred embodiment of the present invention, and is not intended to limit the present invention. The above description is to be understood by those skilled in the art, and thus the other embodiments are not disclosed. Equivalent changes or modifications made in the spirit of the invention are to be included in the scope of the claims below.

1...流體檢測試片1. . . Fluid test strip

10...基板10. . . Substrate

11...流道11. . . Runner

1101...待測物質1101. . . Substance to be tested

111...第一流體區111. . . First fluid zone

1110...纖維層1110. . . Fiber layer

1111...第一抗體1111. . . Primary antibody

1112...醣類材料1112. . . Sugar material

1113...過氧化物脢1113. . . Peroxide

112...第二流體區112. . . Second fluid zone

1120...第二硝化纖維層1120. . . Second nitrocellulose layer

1121...第二抗體1121. . . Secondary antibody

113...第三流體區113. . . Third fluid zone

1130...第三硝化纖維層1130. . . Third nitrocellulose layer

1131...發光劑1131. . . Luminescent agent

1132...受質反應試劑1132. . . Receptor reagent

1133...醣氧化脢1133. . . Glycogen

21、22、23、24、25...步驟21, 22, 23, 24, 25. . . step

第1A圖,為本發明之第一較佳實施例流體檢測試片之示意圖。Fig. 1A is a schematic view showing a fluid detecting test piece according to a first preferred embodiment of the present invention.

第1B圖,為本發明第一較佳實施例流體檢測試片流道中反應材料分佈示意圖。Fig. 1B is a schematic view showing the distribution of reactive materials in the flow path of the fluid detecting test piece according to the first preferred embodiment of the present invention.

第1C圖至第1E圖,為本發明第一較佳實施例流體檢測試片流道中反應材料在不同反應階段的分佈示意圖。1C to 1E are schematic views showing the distribution of reactant materials in different reaction stages in the flow path of the fluid detecting test piece according to the first preferred embodiment of the present invention.

第1F圖至第1H圖,為本發明第一較佳實施例流體檢測試片流道中反應材料其他方式分佈示意圖。1F to 1H are schematic views showing other modes of distribution of reactive materials in the flow path of the fluid detecting test piece according to the first preferred embodiment of the present invention.

第1I圖,為本發明第一較佳實施例流體檢測試片剖面示意圖。Fig. 1I is a schematic cross-sectional view showing a fluid detecting test piece according to a first preferred embodiment of the present invention.

第2圖,為本發明第二較佳實施例流體檢測方法之流程示意圖。Fig. 2 is a flow chart showing a fluid detecting method according to a second preferred embodiment of the present invention.

11‧‧‧流道11‧‧‧ flow path

1101‧‧‧待測物質1101‧‧‧Substance to be tested

111‧‧‧第一流體區111‧‧‧First Fluid Zone

1111‧‧‧第一抗體1111‧‧‧First antibody

1112‧‧‧醣類材料1112‧‧‧Sugar materials

1113‧‧‧過氧化物脢1113‧‧‧ peroxide 脢

112‧‧‧第二流體區112‧‧‧Second fluid zone

1121‧‧‧第二抗體1121‧‧‧Second antibody

113‧‧‧第三流體區113‧‧‧ Third fluid zone

1131‧‧‧發光劑1131‧‧‧Lighting agent

1132‧‧‧受質反應試劑1132‧‧‧Reagents

1133‧‧‧醣氧化脢1133‧‧‧Glycogen

Claims (32)

一種流體檢測試片,主要包含一基板,該基板包含至少一流道,該流道包含依序連接之第一流體區、第二流體區與第三流體區,該第一流體區係供流體之注入,其特徵在於:一第一抗體,位於第一流體區中,用於辨識一待測物質;一醣類材料,位於第一流體區或第二流體區中;一過氧化物脢,位於第一流體區或第二流體區中;一第二抗體,固定於第二流體區中,該第二抗體亦辨識該待測物質,且該第二抗體及該第一抗體係辨識相異之抗原決定位置;以及一發光劑與一受質反應試劑,位於第三流體區中,該受質反應試劑包含有一醣氧化脢;藉此,當一包含有該待測物質之流體注入該流道後,該第一抗體、該醣類材料及該過氧化物脢係隨著該流體流動,部份之過氧化物脢會與該第一抗體、該待測物質及該第二抗體結合並留置於該第二流體區中,未結合之過氧化物脢則隨流體流至該第三流體區,且該醣氧化脢會催化流至該第三流體區之該醣類材料進行氧化反應,並產生出一過氧化氫,且該發光劑會受到流至該第三流體區的該過氧化物脢催化與該過氧化氫進行反應,並產生一光學訊號。A fluid detecting test piece mainly comprises a substrate, the substrate comprising at least a first channel, the flow channel comprising a first fluid zone, a second fluid zone and a third fluid zone connected in sequence, the first fluid zone being for fluid Injecting, characterized in that: a first antibody is located in the first fluid region for identifying a substance to be tested; a sugar material is located in the first fluid region or the second fluid region; a first fluid region or a second fluid region; a second antibody fixed in the second fluid region, the second antibody also identifying the test substance, and the second antibody and the first anti-system are different in identification An antigen determining position; and a luminescent agent and a host reaction reagent, located in the third fluid region, the matrix reaction reagent comprising a sugar cerium oxide; thereby, when a fluid containing the substance to be tested is injected into the flow channel The first antibody, the saccharide material, and the peroxide oxime system flow with the fluid, and a portion of the peroxide oxime is combined with the first antibody, the test substance, and the second antibody and left In the second fluid zone, unbound The peroxide enthalpy flows with the fluid to the third fluid zone, and the saccharide cerium oxide catalyzes the oxidation reaction of the saccharide material flowing to the third fluid zone to generate a hydrogen peroxide, and the luminescent agent The peroxide ruthenium, which is passed to the third fluid zone, is catalyzed by the reaction with the hydrogen peroxide and produces an optical signal. 如申請專利範圍第1項的流體檢測試片,其中該第一抗體與該過氧化物脢同時位於第一流體區中,並形成共軛結合。The fluid test strip of claim 1, wherein the first antibody and the peroxide oxime are simultaneously located in the first fluid zone and form a conjugate bond. 如申請專利範圍第1項的流體檢測試片,其中該第一抗體進一步與一生物素形成共軛結合,而該過氧化物脢係與一親和素形成共軛結合,且該親合素係選自由下列單元所組成群組其中之一者,包括有卵白素、鏈黴親合素,及中性鏈親和素。The fluid detecting test piece according to claim 1, wherein the first antibody further forms a conjugate bond with a biotin, and the peroxide lanthanide forms a conjugate bond with the avidin, and the avidin system One of the groups consisting of the following units, including avidin, streptavidin, and neutral streptavidin. 如申請專利範圍第1項的流體檢測試片,其中該第一抗體係為單株抗體或多株抗體,且該第二抗體係為單株抗體或多株抗體。The fluid test strip according to claim 1, wherein the first anti-system is a monoclonal antibody or a plurality of antibodies, and the second anti-system is a monoclonal antibody or a plurality of antibodies. 如申請專利範圍第1項的流體檢測試片,其中該過氧化物脢係選自由下列單元所組成之群組其中之一者,該群組包括有辣根過氧化物脢、抗壞血酸過氧化物脢及過氧化氫脢。 The fluid test strip of claim 1, wherein the peroxide is selected from the group consisting of horseradish peroxide and ascorbate peroxide.脢 and hydrogen peroxide. 如申請專利範圍第1項的流體檢測試片,其中該發光劑係為3-氨基鄰苯二甲醯肼。 The fluid detecting test piece according to claim 1, wherein the luminescent agent is 3-aminophthalic acid. 如申請專利範圍第1項的流體檢測試片,其中該醣類材料係為葡萄糖,且該醣氧化脢係為葡萄糖氧化脢。 The fluid detecting test piece according to claim 1, wherein the saccharide material is glucose, and the saccharide cerium oxide is glucosinolate. 如申請專利範圍第1項的流體檢測試片,其中該第一流體區之底部包含有一纖維層,且該第一抗體係形成於該纖維層之中。 The fluid test strip of claim 1, wherein the bottom of the first fluid zone comprises a fibrous layer, and the first anti-system is formed in the fibrous layer. 如申請專利範圍第1項的流體檢測試片,進一步包含有一硝化纖維層分別形成於第二流體區與第三流體區之底部,且該第二抗體係固定於該第二流體區之硝化纖維層、該受質反應試劑係形成於該第三流體區之硝化纖維層中。 The fluid detecting test piece according to claim 1 further includes a nitrocellulose layer formed at a bottom of the second fluid region and the third fluid region, respectively, and the second anti-system is fixed to the nitrocellulose of the second fluid region. The layer, the host reaction reagent is formed in the nitrocellulose layer of the third fluid zone. 如申請專利範圍第9項的流體檢測試片,其中該硝化纖維層係為一硝化纖維膜。 The fluid test strip of claim 9, wherein the nitrocellulose layer is a nitrocellulose membrane. 如申請專利範圍第9項的流體檢測試片,其中該硝化纖維層係以硝化纖維溶液經澆注於第二流體區與第三流體區之底部再經乾燥後所形成,且該硝化纖維層包含有中空網狀構型。 The fluid detecting test piece according to claim 9 , wherein the nitrocellulose layer is formed by casting a nitrocellulose solution into the bottom of the second fluid zone and the third fluid zone and drying, and the nitrocellulose layer comprises There is a hollow mesh configuration. 如申請專利範圍第11項的流體檢測試片,其中該硝化纖維溶液係以硝化纖維粉末混合酯類及酮類溶劑所形成。 The fluid test piece according to claim 11, wherein the nitrocellulose solution is formed by mixing a nitrocellulose powder ester and a ketone solvent. 如申請專利範圍第12項的流體檢測試片,其中該硝化纖維粉末與酯類及酮類溶劑所混合的較佳比例為1:9。 A fluid detecting test piece according to claim 12, wherein a preferred ratio of the nitrocellulose powder to the ester and the ketone solvent is 1:9. 如申請專利範圍第11項的流體檢測試片,其中該基板為生物相容材料。 The fluid test strip of claim 11, wherein the substrate is a biocompatible material. 如申請專利範圍第11項的流體檢測試片,其中該第二流體區的硝化纖維層平均厚度等於該第三流體區硝化纖維層厚度。 The fluid test strip of claim 11, wherein the average thickness of the nitrocellulose layer of the second fluid zone is equal to the thickness of the nitrocellulose layer of the third fluid zone. 如申請專利範圍第15項的流體檢測試片,其中該流道進一步包括第四流體 區,該第四流體區之底部亦形成有硝化纖維層,該硝化纖維層包含有中空網狀構型,供多餘流體之貯存。 The fluid detecting test piece of claim 15, wherein the flow path further comprises a fourth fluid A nitrocellulose layer is also formed at the bottom of the fourth fluid zone, and the nitrocellulose layer comprises a hollow network configuration for storage of excess fluid. 一種流體檢測方法,包含有下列步驟:提供一流體,該流體包含有一待測物質;提供一基板,該基板包含至少一流道,該流道包含依序連接之第一流體區、第二流體區與第三流體區,該第一流體區係供流體之注入,該基板進一步包含有:一第一抗體,位於第一流體區中,用於辨識該流體內之該待測物質;一醣類材料,位於第一流體區或第二流體區中;一過氧化物脢,位於第一流體區或第二流體區中;一第二抗體,固定於第二流體區中,該第二抗體亦辨識該待測物質,且該第二抗體及該第一抗體係辨識相異之抗原決定位置;以及一發光劑與一受質反應試劑,位於第三流體區中,該受質反應試劑包含有一醣氧化脢;將該流體加至該流道之第一流體區,使該第一抗體、該醣類材料及該過氧化物脢隨著該流體流動;使該待測物質與該第一抗體、該第二抗體及部份之過氧化物脢結合並留置於該第二流體區中,使該流體帶著該醣類材料、未結合之第一抗體及過氧化物脢流至該第三流體區,使該醣類材料受到該醣氧化脢之催化進行氧化反應,並產生出過氧化氫,該發光劑會受到流至該第三流體區的該過氧化物脢催化與該過氧化氫進行反應,並產生一光學訊號;以及偵測該光學訊號,藉由該光學訊號的強度推算出流至該第三流體區之該過氧化物脢的含量,並由該過氧化物脢於添加時之一已知固定含量與該過氧化物脢流至該第三流體區之含量兩者簡單相減以獲得留置於該第二流體區中之該過氧化物脢之含量,再以留置於該第二流體區中之該過氧化物脢的含量推算出留置於該第二流體區中之該過氧化物脢的濃度,最後依留置於該第二流 體區中之該過氧化物脢的濃度推算出該流體中所含該待測物質的濃度。 A fluid detecting method comprising the steps of: providing a fluid comprising a substance to be tested; providing a substrate comprising at least a first channel, the flow channel comprising a first fluid zone and a second fluid zone sequentially connected And the third fluid region, the first fluid region is for the injection of the fluid, the substrate further comprises: a first antibody, located in the first fluid region, for identifying the substance to be tested in the fluid; The material is located in the first fluid zone or the second fluid zone; a peroxide buffer is located in the first fluid zone or the second fluid zone; a second antibody is fixed in the second fluid zone, and the second antibody is also Identifying the test substance, and the second antibody and the first anti-system identify different antigen-determining positions; and a luminescent agent and a host reaction reagent are located in the third fluid region, and the host reaction reagent comprises a saccharide oxide; adding the fluid to the first fluid zone of the flow channel to cause the first antibody, the saccharide material, and the peroxide raft to flow with the fluid; and the test substance and the first antibody Second antibody a portion of the peroxide oxime is bound and left in the second fluid zone, such that the fluid carries the saccharide material, the unbound primary antibody, and the peroxide to the third fluid zone to cause the sugar The material is oxidized by the saccharide cerium oxide and generates hydrogen peroxide, and the luminescent agent is catalyzed by the peroxide ruthenium flowing to the third fluid region to react with the hydrogen peroxide, and a Optical signal; and detecting the optical signal, estimating the content of the peroxide enthalpy flowing to the third fluid region by the intensity of the optical signal, and fixing the peroxide enthalpy to one of the additives The content is simply subtracted from the content of the peroxide turbulent flow to the third fluid zone to obtain the content of the peroxide oxime remaining in the second fluid zone, and then left in the second fluid zone. The content of the peroxide enthalpy deduces the concentration of the peroxide enthalpy remaining in the second fluid zone, and finally remains in the second stream The concentration of the peroxide oxime in the body region is derived from the concentration of the test substance contained in the fluid. 如申請專利範圍第17項的流體檢測方法,其中該第一抗體與該過氧化物脢同時位於第一流體區中,並形成共軛結合。 The fluid detecting method of claim 17, wherein the first antibody and the peroxide oxime are simultaneously located in the first fluid region and form a conjugate bond. 如申請專利範圍第17項的流體檢測方法,其中該第一抗體進一步與一生物素形成共軛結合,而該過氧化物脢係與一親和素形成共軛結合,且該親合素係選自由下列單元所組成群組其中之一者,包括有卵白素、鏈黴親合素,及中性鏈親和素。 The fluid detecting method of claim 17, wherein the first antibody further forms a conjugate bond with a biotin, and the peroxide lanthanide forms a conjugate bond with the avidin, and the avidin is selected One of the groups consisting of the following units, including avidin, streptavidin, and neutral streptavidin. 如申請專利範圍第17項的流體檢測方法,其中該第一抗體係為單株抗體或多株抗體,且該第二抗體係為單株抗體或多株抗體。 The fluid detecting method according to claim 17, wherein the first anti-system is a monoclonal antibody or a plurality of antibodies, and the second anti-system is a monoclonal antibody or a plurality of antibodies. 如申請專利範圍第17項的流體檢測方法,其中該過氧化物脢係選自由下列單元所組成之群組其中之一者,該群組包括有辣根過氧化物脢、抗壞血酸過氧化物脢及過氧化氫脢。 The fluid detecting method according to claim 17, wherein the peroxide oxime is selected from the group consisting of the following units, the group comprising horseradish peroxide 抗, ascorbyl peroxide 脢And hydrazine hydroperoxide. 如申請專利範圍第17項的流體檢測方法,其中該發光劑係為3-氨基鄰苯二甲醯肼。 The fluid detecting method according to claim 17, wherein the luminescent agent is 3-aminophthalic acid. 如申請專利範圍第17項的流體檢測方法,其中該醣類材料係為葡萄糖,且該醣氧化脢係為葡萄糖氧化脢。 The fluid detecting method according to claim 17, wherein the saccharide material is glucose, and the saccharide cerium oxide is glucosinolate. 如申請專利範圍第17項的流體檢測方法,其中該第一流體區之底部包含有一纖維層,且該第一抗體係形成於該纖維層之中。 The fluid detecting method of claim 17, wherein the bottom of the first fluid zone comprises a fibrous layer, and the first resistant system is formed in the fibrous layer. 如申請專利範圍第17項的流體檢測方法,進一步包含有一硝化纖維層分別形成於第二流體區與第三流體區之底部,且該第二抗體係固定於該第二流體區之硝化纖維層、該受質反應試劑係形成於該第三流體區之硝化纖維層中。 The fluid detecting method of claim 17, further comprising a nitrocellulose layer formed at a bottom of the second fluid zone and the third fluid zone, respectively, and the second anti-system is fixed to the nitrocellulose layer of the second fluid zone. The host reaction reagent is formed in the nitrocellulose layer of the third fluid zone. 如申請專利範圍第25項的流體檢測方法,其中該硝化纖維層係為一硝化纖維膜。 The fluid detecting method of claim 25, wherein the nitrocellulose layer is a nitrocellulose membrane. 如申請專利範圍第25項的流體檢測方法,其中該硝化纖維層係以硝化纖維溶液經澆注於第二流體區與第三流體區之底部再經乾燥後所形成,且該硝 化纖維層包含有中空網狀構型。 The fluid detecting method of claim 25, wherein the nitrocellulose layer is formed by pouring a nitrocellulose solution into the bottom of the second fluid zone and the third fluid zone and drying, and the nitrate is formed. The chemical fiber layer contains a hollow network configuration. 如申請專利範圍第27項的流體檢測方法,其中該硝化纖維溶液係以硝化纖維粉末混合酯類及酮類溶劑所形成。 The fluid detecting method according to claim 27, wherein the nitrocellulose solution is formed by mixing a nitrocellulose powder ester and a ketone solvent. 如申請專利範圍第28項的流體檢測方法,其中該硝化纖維粉末與酯類及酮類溶劑所混合的較佳比例為1:9。 The fluid detecting method according to claim 28, wherein a preferred ratio of the nitrocellulose powder to the ester and the ketone solvent is 1:9. 如申請專利範圍第25項的流體檢測方法,其中該基板為生物相容材料。 The fluid detecting method of claim 25, wherein the substrate is a biocompatible material. 如申請專利範圍第27項的流體檢測方法,其中該第二流體區的硝化纖維層平均厚度等於該第三流體區硝化纖維層厚度。 The fluid detecting method of claim 27, wherein the average thickness of the nitrocellulose layer of the second fluid zone is equal to the thickness of the nitrocellulose layer of the third fluid zone. 如申請專利範圍第31項的流體檢測方法,其中該流道進一步包括第四流體區,該第四流體區之底部亦形成有硝化纖維層,該硝化纖維層包含有中空網狀構型,供多餘流體之貯存。 The fluid detecting method of claim 31, wherein the flow path further comprises a fourth fluid zone, and a bottom of the fourth fluid zone is also formed with a nitrocellulose layer, the nitrocellulose layer comprising a hollow mesh structure for Storage of excess fluid.
TW097139825A 2008-10-17 2008-10-17 Detecting strip and the detecting method using the same TWI385384B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW097139825A TWI385384B (en) 2008-10-17 2008-10-17 Detecting strip and the detecting method using the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW097139825A TWI385384B (en) 2008-10-17 2008-10-17 Detecting strip and the detecting method using the same

Publications (2)

Publication Number Publication Date
TW201017160A TW201017160A (en) 2010-05-01
TWI385384B true TWI385384B (en) 2013-02-11

Family

ID=44830711

Family Applications (1)

Application Number Title Priority Date Filing Date
TW097139825A TWI385384B (en) 2008-10-17 2008-10-17 Detecting strip and the detecting method using the same

Country Status (1)

Country Link
TW (1) TWI385384B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2348316B1 (en) 2008-10-09 2013-08-28 Actherm Inc. A method for testing a liquid
EP2352026B1 (en) 2008-10-17 2013-08-14 Actherm Inc. Liquid test strip and the method
EP2339019B1 (en) 2008-10-17 2013-08-14 Actherm Inc. A fluid test strip and method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW374116B (en) * 1996-08-07 1999-11-11 Apex Bio Technology Corp Process for preparing a primary sheet type electrode and bio-active membrane

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW374116B (en) * 1996-08-07 1999-11-11 Apex Bio Technology Corp Process for preparing a primary sheet type electrode and bio-active membrane

Also Published As

Publication number Publication date
TW201017160A (en) 2010-05-01

Similar Documents

Publication Publication Date Title
WO2010043075A1 (en) Liquid test strip and the method
CN102076415B (en) Liquid-transfer device particularly useful as a capturing device in a biological assay process
KR20130037647A (en) A method of producing membrane sensor for changing the condition of reaction sequentially with one injection of sample
TWI385384B (en) Detecting strip and the detecting method using the same
KR101990301B1 (en) Optical biosensor
TWI385380B (en) Detecting strip and method for fluid analysis
WO2010043074A1 (en) A fluid test strip and method thereof
JP2011530703A (en) Analytical strip
KR101178014B1 (en) A method for testing a liquid
JP2012502261A (en) Combination test strip
TWI398636B (en) Detecting method of liquid sample
TW201013183A (en) Combinatory testing strip
NZ591987A (en) Liquid test strip and the method
NZ591986A (en) A fluid test strip and method thereof
JPWO2006004039A1 (en) Immunoassay apparatus and method

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees